Coorporate Communication

CIKARANG, June 9, 2026 – PT Pyridam Farma Tbk (IDX: PYFA), in collaboration with the National Agency of Drug and

CIKARANG, June 4, 2026 – The Head of the Indonesian Food and Drug Authority (BPOM), Prof. dr. Taruna Ikrar, M.Biomed.,

JAKARTA, June 3, 2026 – PT Pyridam Farma Tbk (IDX: PYFA) recorded positive performance in the first quarter of 2026

JAKARTA, MAY 25, 2026 – PT Pyridam Farma Tbk (IDX: PYFA) has officially announced the resignation of Robby Yulianto from

JAKARTA, May 21 2026 – Amid growing public concern over the spread of Hantavirus, PT Pyridam Farma Tbk (IDX: PYFA) is urging

JAKARTA, May 16 2026 – PT Pyridam Farma Tbk (IDX: PYFA) has officially established the PYFA Health Sports Community as a tangible

PT Pyridam Farma Tbk (IDX: PYFA) is executing its Capital Increase with Pre-emptive Rights II (PMHMETD II), commonly known as

JAKARTA, 7 April 2026 – PT Pyridam Farma Tbk (IDX: PYFA) recorded accelerated growth in the 2025 fiscal year with

CIANJUR, 16 March 2026 – In an effort to strengthen safe and sustainable operational practices, PT Pyridam Farma Tbk (PYFA) has reaffirmed

CIKARANG, March 3, 2026 – PT Ethica Industri Farmasi (“PT EIF”), a pharmaceutical company specializing in sterile injectable products and